AfroCentric Investment Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Gerald Van Wyk
Chief Executive Officer (CEO)
R6.4m
Compensación total
| Porcentaje del salario del CEO | 64.4% |
| Permanencia del CEO | 1.3yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 2.8yrs |
| Promedio de permanencia en la Junta Directiva | 5.3yrs |
Actualizaciones recientes de la dirección
Recent updates
AfroCentric Investment Corporation Limited's (JSE:ACT) 29% Price Boost Is Out Of Tune With Earnings
Sep 01
Pinning Down AfroCentric Investment Corporation Limited's (JSE:ACT) P/E Is Difficult Right Now
May 02Here's Why We Think AfroCentric Investment Corporation Limited's (JSE:ACT) CEO Compensation Looks Fair for the time being
Nov 04AfroCentric Investment (JSE:ACT) Has Announced A Dividend Of ZAR0.17
Oct 26AfroCentric Investment (JSE:ACT) Is Due To Pay A Dividend Of ZAR0.17
Oct 12AfroCentric Investment (JSE:ACT) Will Pay A Dividend Of ZAR0.17
Sep 16AfroCentric Investment (JSE:ACT) Will Pay A Dividend Of R0.17
Oct 03AfroCentric Investment's (JSE:ACT) Dividend Will Be R0.17
Sep 16Is Now The Time To Put AfroCentric Investment (JSE:ACT) On Your Watchlist?
Sep 05I Built A List Of Growing Companies And AfroCentric Investment (JSE:ACT) Made The Cut
Jun 04How Does AfroCentric Investment Corporation Limited (JSE:ACT) Fare As A Dividend Stock?
Apr 28I Built A List Of Growing Companies And AfroCentric Investment (JSE:ACT) Made The Cut
Feb 24Why AfroCentric Investment Corporation Limited (JSE:ACT) Should Be In Your Dividend Portfolio
Jan 18AfroCentric Investment's (JSE:ACT) Shareholders Are Down 44% On Their Shares
Dec 22
Here's Why I Think AfroCentric Investment (JSE:ACT) Is An Interesting Stock
Nov 25Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | R6m | R4m | R55m |
Compensación vs. Mercado: La compensación total ($USD351.05K) de Gerald está en línea con el promedio de empresas de tamaño similar en el mercado ZA ($USD355.05K).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Gerald con los resultados de la empresa.
CEO
Gerald Van Wyk
1.3yrs
Permanencia
R6,357,000
Compensación
Mr. Gerald Van Wyk is Group Chief Executive Officer & Director of AfroCentric Investment Corporation Limited from August 01, 2023. He is the former CEO: Client Solutions for Santam where he was responsible...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Group CEO & Director | 1.3yrs | R6.36m | sin datos | |
| Group CFO & Executive Director | 9.3yrs | R7.91m | 0.000090% ZAR 1.9k | |
| Group Technology Director | 2.8yrs | sin datos | sin datos | |
| GM of Legal | no data | sin datos | sin datos | |
| Group Executive of Human Capital & Transformation | 2.8yrs | sin datos | sin datos | |
| Group Company Secretary | less than a year | sin datos | sin datos |
2.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de ACT se considera experimentado (2.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Group CEO & Director | 1.3yrs | R6.36m | sin datos | |
| Group CFO & Executive Director | 9.3yrs | R7.91m | 0.000090% ZAR 1.9k | |
| Non-Executive Chairperson | 14.4yrs | R1.85m | sin datos | |
| Non-Executive Deputy Chairman | 14.4yrs | R2.09m | sin datos | |
| Non-Executive Director | 1.4yrs | sin datos | sin datos | |
| Non-Executive Director | 8.9yrs | R599.00k | 0.00085% ZAR 18.3k | |
| Non-Executive Director | 1.4yrs | R409.00k | sin datos | |
| Lead Independent Non-Executive Director | 6yrs | R1.25m | sin datos | |
| Independent Non-Executive Director | 4.5yrs | R735.00k | 0.0022% ZAR 46.5k | |
| Non-Executive Director | 2.4yrs | sin datos | sin datos |
5.3yrs
Permanencia media
56.5yo
Promedio de edad
Junta con experiencia: La junta directiva de ACT se considera experimentada (5.3 años de antigüedad promedio).